32 3 
Home Page  

  • SciELO

  • Google
  • SciELO
  • Google


Actas Urológicas Españolas

 ISSN 0210-4806

BESTARD VALLEJO, J.E. et al. Renal angiomyolipoma: presentation, treatment and results of 20 cases. []. , 32, 3, pp.307-315. ISSN 0210-4806.

Introduction: Renal angiomyolipoma is a benign tumour, but its spontaneous rupture may become threatening for patient’s live. Both surgery and selective arterial embolization are accepted treatments for this lesion. Objectives: Analyze renal angyolipoma treated in our center, their clinical outcome and treatment purposed in each case. Material and Methods: We retrospectively analyse 20 cases of patients with renal angiomyolipoma treated in our centre from March 1996 to March 2006. We describe tumour characteristics, treatment followed and results obtained. Results: Patients suffering from tuberous sclerosis (20%) showed multiple bilateral tumours, with size similar to the rest of patients. Diagnosis of tuberous sclerosis was the only factor attached to spontaneous rupture of those lesions. Four of 9 emergency embolized patients (44.4%) required from second treatment because of recurrent haemorrhage, and 4 of the 16 embolization episodes (25%) presented post-embolization syndrome, both with no predicting factors attached. Reduction of less than one third of the inicial diameter was observed in 58.4% of embolized tumours, which used to be multiple, bilateral and of size larger to the rest. No significative differences were observed in plasmatic creatinine after and before treatments. Conclusions: Renal angiomyolipoma may behave in an aggressive way in patients with tuberous sclerosis. No predicting factors of recurrent haemorrhage or post-embolization syndrome were observed. Both surgery and arterial embolization have proved not to compromise renal function in treated patients.

: Renal angiomyolipoma; Selective embolization; Tuberous sclerosis complex.

        · |     · |     · ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License